- Home
- SPH vs PLSE Comparison
SPH vs PLSE Comparison
Compare SPH & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- PLSE
- Stock Information
- Founded
- SPH 1945
- PLSE 2014
- Country
- SPH United States
- PLSE United States
- Employees
- SPH N/A
- PLSE N/A
- Industry
- SPH Other Specialty Stores
- PLSE Medical/Dental Instruments
- Sector
- SPH Consumer Discretionary
- PLSE Health Care
- Exchange
- SPH Nasdaq
- PLSE Nasdaq
- Market Cap
- SPH 1.2B
- PLSE 1.2B
- IPO Year
- SPH 1996
- PLSE 2016
- Fundamental
- Price
- SPH $21.84
- PLSE $23.57
- Analyst Decision
- SPH Hold
- PLSE
- Analyst Count
- SPH 3
- PLSE 0
- Target Price
- SPH $19.67
- PLSE N/A
- AVG Volume (30 Days)
- SPH 303.8K
- PLSE 127.7K
- Earning Date
- SPH 02-06-2025
- PLSE 03-27-2025
- Dividend Yield
- SPH 5.98%
- PLSE N/A
- EPS Growth
- SPH N/A
- PLSE N/A
- EPS
- SPH 1.14
- PLSE N/A
- Revenue
- SPH $1,327,172,000.00
- PLSE N/A
- Revenue This Year
- SPH N/A
- PLSE N/A
- Revenue Next Year
- SPH N/A
- PLSE N/A
- P/E Ratio
- SPH $19.07
- PLSE N/A
- Revenue Growth
- SPH N/A
- PLSE N/A
- 52 Week Low
- SPH $15.20
- PLSE $6.60
- 52 Week High
- SPH $21.79
- PLSE $23.62
- Technical
- Relative Strength Index (RSI)
- SPH 76.49
- PLSE 59.71
- Support Level
- SPH $19.57
- PLSE $17.35
- Resistance Level
- SPH $21.49
- PLSE $22.05
- Average True Range (ATR)
- SPH 0.84
- PLSE 1.22
- MACD
- SPH 0.27
- PLSE 0.26
- Stochastic Oscillator
- SPH 98.79
- PLSE 65.91
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.